News

BioM's articles and press releases about the Bavarian biotechnology sector


Research on therapeutics against COVID-19: Ilse Aigner visits Pieris

State Parlia­ment Pres­id­ent Ilse Aign­er and other polit­ic­al rep­res­ent­at­ives vis­ited the bi­otech com­pany Pier­is…

Climedo raises 5 million euros for digital clinical trials

Mu­nich-based health tech com­pany Climedo has re­ceived five mil­lion euros in a seed fin­an­cing round. The lead in­vestor is the…

BioVaria 2022 in Munich: Application deadline for Startup Pitch & Partner until March 1

European life sci­ence star­tups from all life sci­ence areas can apply for the in­ter­act­ive two-day BioVaria Star­tup Pitch & Part­ner…

Transnational EU-project CE4BIG on cluster management excellence and SME support draws to a close

With­in the CE4BIG pro­ject, BioM has col­lab­or­ated with the other European health­care clusters BioWin, Klaster LifeS­cience Krakow and…

Ethris continues research on mRNA therapeutics with fresh USD 26.3m - including against SARS-CoV-2

Planegg-based bi­o­tech­no­logy com­pany Ethris has raised $26.3 mil­lion (€23.3 mil­lion) in a Ser­ies B fund­ing round led by Laureus…

Automated protein analysis to raise 13.5 million for PreOmics

Martin­sried, Ger­many-based PreOm­ics has re­ceived EUR 13.5 mil­lion in Ser­ies B fin­an­cing from Bruker Co­op­er­a­tion. This is…

MedtecLIVE with T4M - medtech spring event

At MedtecLIVE with T4M, which will be held in Stut­tgart from May 3-5, 2022, product de­velopers and buy­ers from dis­trib­ut­ors and OEMs…

A spray against lung damage due to COVID-19

The start-up rnat­ics of the Tech­nic­al University of Mu­nich (TUM) has de­veloped an RNA-based act­ive sub­stance against in­flam­mat­ory…

Parkinson's and multiple sclerosis: Regensburg-based Lifespin continues research with 2.5 million euros

Re­gens­burg-based Biopark Lifespin GmbH has suc­cess­fully closed a €2.5 mil­lion bridge fin­an­cing. The dia­gnost­ic data com­pany is…

Newsletter

Subscribe

Archive


20.11.2024

vfa bio Biotechnologie im Verband Forschender Arzneimittelhersteller e.V.

Gen- und Zell­ther­api­en sind Teil der Zukun­ftsmed­iz­in

19.11.2024

Friedrich-Alexander-Universität Erlangen-Nürnberg

FAU-Wis­senschaftler unter den meistzit­ier­ten ihres Faches

19.11.2024

Technische Universität München

15 Forschende unter den welt­weit meistzit­ier­ten


Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager